Skip to content
2000
Volume 25, Issue 6
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Background

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) can cause acute and chronic viral infections. Due to their higher costs, potential side effects and drug interactions, and associated risks, some patients with HCV and HBV infections may not be able to afford conventional antiviral medications.

Objective

The goal of this review paper is to highlight the advantages of , or black seeds, in the treatment of patients with HCV and HBV infections.

Methods

Medline/Pubmed/PMC, Scopus, Web of Science, Google Scholar, Science Direct, Ebsco, Embase, and reference lists were searched to locate the research studies that assessed the effects of different black seed () preparations on the telltale signs and symptoms of HCV and HBV infections.

Results

Numerous preclinical and clinical investigations have suggested that black seeds () may be effective against HCV and HBV infections. Furthermore, , or black seeds, have demonstrated a range of pleiotropic effects, such as antiviral activity against multiple other viruses and anti-inflammatory, antioxidant, and immunomodulatory properties that can lessen the symptoms and indicators of HCV and HBV infections.

Conclusion

Patients with HCV and HBV infections may benefit from using black seeds () as an adjuvant therapy in addition to conventional therapy. Additional randomized controlled clinical trials would confirm the safety and effectiveness of (black seeds) in treating HCV and HBV infections.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265331112250115061024
2025-02-20
2025-10-18

  • From This Site

    /content/journals/iddt/10.2174/0118715265331112250115061024
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. OdenwaldM.A. PaulS. Viral hepatitis: Past, present, and future.World J. Gastroenterol.202228141405142910.3748/wjg.v28.i14.1405 35582678
     [Google Scholar]
  2. GhulamF. ZakariaN. MajeedM.I. IsmailF. Viral hepatitis-The road traveled and the journey remaining.Hepat. Med.202214132610.2147/HMER.S352568 35300491
     [Google Scholar]
  3. PisanoM.B. GiadansC.G. FlichmanD.M. RéV.E. PreciadoM.V. ValvaP. Viral hepatitis update: Progress and perspectives.World J. Gastroenterol.202127264018404410.3748/wjg.v27.i26.4018 34326611
     [Google Scholar]
  4. KimC.W. ChangK.M. Hepatitis C virus: Virology and life cycle.Clin. Mol. Hepatol.2013191172510.3350/cmh.2013.19.1.17 23593605
     [Google Scholar]
  5. PietschmannT. BrownR.J.P. Hepatitis C virus.Trends Microbiol.201927437938010.1016/j.tim.2019.01.001 30709707
     [Google Scholar]
  6. DattaS. ChatterjeeS. VeerV. ChakravartyR. Molecular biology of the hepatitis B virus for clinicians.J. Clin. Exp. Hepatol.20122435336510.1016/j.jceh.2012.10.003 25755457
     [Google Scholar]
  7. AlterM. HCV routes of transmission: What goes around comes around.Semin. Liver Dis.201131434034610.1055/s‑0031‑1297923 22189974
     [Google Scholar]
  8. TrickeyA. FraserH. LimA.G. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: A modelling study.Lancet Gastroenterol. Hepatol.20194643544410.1016/S2468‑1253(19)30085‑8 30981685
     [Google Scholar]
  9. KayondoS.P. ByamugishaJ.K. NtuyoP. Prevalence of hepatitis B virus infection and associated risk factors among pregnant women attending antenatal clinic in Mulago Hospital, Uganda: A cross-sectional study.BMJ Open2020106e03304310.1136/bmjopen‑2019‑033043 32499255
     [Google Scholar]
  10. BlachS. ZeuzemS. MannsM. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study.Lancet Gastroenterol. Hepatol.20172316117610.1016/S2468‑1253(16)30181‑9 28404132
     [Google Scholar]
  11. BlachS. TerraultN.A. TackeF. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study.Lancet Gastroenterol. Hepatol.20227539641510.1016/S2468‑1253(21)00472‑6 35180382
     [Google Scholar]
  12. BrunnerN. BruggmannP. Trends of the global hepatitis C disease burden: Strategies to achieve elimination.J. Prev. Med. Public Health202154425125810.3961/jpmph.21.151 34370938
     [Google Scholar]
  13. YazdaniK. DolguikhK. ZhangW. Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy.PLoS One2022173e026581110.1371/journal.pone.0265811 35320316
     [Google Scholar]
  14. ShearerR.D. GamkrelidzeI. NguyenM.H. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study.Lancet Gastroenterol. Hepatol.20183638340310.1016/S2468‑1253(18)30056‑6 29599078
     [Google Scholar]
  15. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. 2021. Available from: https://www.who.int/publications/i/item/9789240053779 [Accessed on: 9th Aug 2022].
  16. HashemM. ZaghlaH. ZakariaZ. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.J. Med. Virol.201890121841184710.1002/jmv.25270 30011346
     [Google Scholar]
  17. BoesL. HouareauC. AltmannD. Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014.Public Health202018014114810.1016/j.puhe.2019.11.012 31918048
     [Google Scholar]
  18. WongR.J. GishR.G. Metabolic manifestations and complications associated with chronic hepatitis C virus infection.Gastroenterol. Hepatol.2016125293299 27499712
     [Google Scholar]
  19. ChaudhariR. FoudaS. SainuA. PappachanJ.M. Metabolic complications of hepatitis C virus infection.World J. Gastroenterol.202127131267128210.3748/wjg.v27.i13.1267 33833481
     [Google Scholar]
  20. WrightT.L. Introduction to chronic hepatitis B infection.Am. J. Gastroenterol.2006101S1S6
     [Google Scholar]
  21. ZamorP.J. deLemosA.S. RussoM.W. Viral hepatitis and hepatocellular carcinoma: Etiology and management.J. Gastrointest. Oncol.20178222924210.21037/jgo.2017.03.14 28480063
     [Google Scholar]
  22. ZhangX. GuanL. TianH. Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma.Front. Oncol.20211168696210.3389/fonc.2021.686962 34568017
     [Google Scholar]
  23. YuenM.F. ChenD.S. DusheikoG.M. Hepatitis B virus infection.Nat. Rev. Dis. Primers2018411803510.1038/nrdp.2018.35 29877316
     [Google Scholar]
  24. MohantyA. SalamehS. ButtA.A. Impact of direct acting antiviral agent therapy upon extrahepatic manifestations of hepatitis C virus infection.Curr. HIV/AIDS Rep.201916538939410.1007/s11904‑019‑00466‑1 31482299
     [Google Scholar]
  25. LiawY.F. ChuC.M. Hepatitis B virus infection.Lancet2009373966358259210.1016/S0140‑6736(09)60207‑5 19217993
     [Google Scholar]
  26. LiangJ.T. HepatitisB. The virus and disease #.Hepatology2009495S13S2110.1002/hep.22881 19399811
     [Google Scholar]
  27. TrépoC. ChanH.L.Y. LokA. Hepatitis B virus infection.Lancet201438499592053206310.1016/S0140‑6736(14)60220‑8 24954675
     [Google Scholar]
  28. World Health Organization. Hepatitis C. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c [Accessed on: 27th Mar 2024].
  29. OgunnaikeM. DasS. RautS.S. Chronic hepatitis B infection: New approaches towards cure.Biomolecules2023138120810.3390/biom13081208 37627273
     [Google Scholar]
  30. World Health Organization. Hepatitis B. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b [Accessed on: 04th Apr 2024].
  31. MengX. PanZ. ZhaoJ. FengQ. Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis.Medicine202210146e3166410.1097/MD.0000000000031664 36401442
     [Google Scholar]
  32. YuX.I.A. XinL.I. RongyongM.A.N. AibingW.A.N.G. JianzhongC.A.O. Clinical efficacy and safety of TCM prescriptions combined with nucleoside (acid) analogues in treating chronic hepatitis B: A meta-analysis.Digit. Chin. Med.20214317017910.1016/j.dcmed.2021.09.002
     [Google Scholar]
  33. KimS. LeeY. ChoN. ChoiH. KimK. Herbal medicine for the treatment of viral hepatitis B and C: A systematic review of randomized controlled trials.J Int Korean Med202142445547410.22246/jikm.2021.42.4.455
     [Google Scholar]
  34. WangT. JinW. HuangQ. Clinical efficacy and safety of eight traditional chinese medicine combined with entecavir in the treatment of chronic hepatitis B liver fibrosis in adults: A network meta‐analysis.Evid. Based Complement. Alternat. Med.202020201760341010.1155/2020/7603410 33062022
     [Google Scholar]
  35. LiuJ. ManheimerE. TsutaniK. GluudC. Medicinal herbs for hepatitis C virus infection: A cochrane hepatobiliary systematic review of randomized trials.Am. J. Gastroenterol.200398353854410.1111/j.1572‑0241.2003.07298.x 12650784
     [Google Scholar]
  36. McCullochM. BroffmanM. GaoJ. ColfordJ.M.Jr Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: A meta-analysis of randomized, controlled trials.Am. J. Public Health200292101619162810.2105/AJPH.92.10.1619 12356611
     [Google Scholar]
  37. LiuJ. McIntoshH. LinH. Chinese medicinal herbs for chronic hepatitis B: A systematic review.Liver200121428028610.1034/j.1600‑0676.2001.021004280.x 11454192
     [Google Scholar]
  38. MaideenN.M.P. Prophetic medicine-Nigella sativa (Black cumin seeds) - potential herb for COVID-19?J. Pharmacopuncture2020232627010.3831/KPI.2020.23.010 32685234
     [Google Scholar]
  39. DabeerS. RatherM.A. RasoolS. History and traditional uses of black seeds (Nigella sativa).Black Seeds (Nigella sativa).Elsevier2022128
     [Google Scholar]
  40. SalehiB. QuispeC. ImranM. Nigella plants-Traditional uses, bioactive phytoconstituents, preclinical and clinical studies.Front. Pharmacol.20211262538610.3389/fphar.2021.625386 33981219
     [Google Scholar]
  41. MajeedA. MuhammadZ. AhmadH. Nigella sativa L.: Uses in traditional and contemporary medicines - An overview.Acta Ecol. Sin.202141425325810.1016/j.chnaes.2020.02.001
     [Google Scholar]
  42. KhanS. AliM. AlbrattyM.M. Nigella sativa: From chemistry to medicine.Black Seeds (Nigella sativa).Elsevier20222962
     [Google Scholar]
  43. IslamM.T. KhanM.R. MishraS.K. An updated literature-based review: Phytochemistry, pharmacology and therapeutic promises of Nigella sativa L.Orient. Pharm. Exp. Med.201919211512910.1007/s13596‑019‑00363‑3
     [Google Scholar]
  44. DalliM. BekkouchO. AziziS. AzgharA. GseyraN. KimB. Nigella sativa L. phytochemistry and pharmacological activities: A review (2019-2021).Biomolecules20211212010.3390/biom12010020 35053168
     [Google Scholar]
  45. DhaheriA.Y. WaliA.F. AkbarI. Nigella sativa, a cure for every disease: Phytochemistry, biological activities, and clinical trials. Black seeds (Nigella sativa).Black seeds (Nigella sativa): Pharmacological and therapeutic applications.Elsevier2022639010.1016/B978‑0‑12‑824462‑3.00011‑1
     [Google Scholar]
  46. TiwariP. JenaS. SatpathyS. SahuP.K. Nigella sativa: Phytochemistry, pharmacology and its therapeutic potential.Res J Pharm Technol20191273111311610.5958/0974‑360X.2019.00526.2
     [Google Scholar]
  47. LalG. MeenaS.S. LalS. Nigella (Nigella sativa L.), a novel herb can cure many diseases: A review.Int J Seed Spices2020101110
     [Google Scholar]
  48. BegumS. MannanA. A review on Nigella sativa: A marvel herb.J. Drug Deliv. Ther.202010221321910.22270/jddt.v10i2.3913
     [Google Scholar]
  49. KhotbehsaraD.R. GolzarandM. GhaffariM.P. DjafarianK. Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis.Complement. Ther. Med.20173561310.1016/j.ctim.2017.08.016 29154069
     [Google Scholar]
  50. BadarA. KaatabiH. BamosaA. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: Nonrandomized clinical trial.Ann. Saudi Med.2017371566310.5144/0256‑4947.2017.56 28151458
     [Google Scholar]
  51. PiseH. PadwalS. Evaluation of anti-inflammatory activity of Nigella sativa: An experimental study.Natl. J. Physiol. Pharm. Pharmacol.201776110.5455/njppp.2017.7.0204705032017
     [Google Scholar]
  52. AndradeP.H.M. RondonS.E. CarolloC.A. Effect of powdered shells of the snail Megalobulimus lopesi on secondary-intention wound healing in an animal model.Evid. Based Complement. Alternat. Med.201520151910.1155/2015/120785 25821475
     [Google Scholar]
  53. StockS.R. FakhouryI.H. ZakiA.M. BabaE.C.O. MuhtasibG.H.U. Thymoquinone: Fifty years of success in the battle against cancer models.Drug Discov. Today2014191183010.1016/j.drudis.2013.08.021 24001594
     [Google Scholar]
  54. BarakatE.M.F. WakeelE.L.M. HagagR.S. Effects of Nigella sativa on outcome of hepatitis C in Egypt.World J. Gastroenterol.201319162529253610.3748/wjg.v19.i16.2529 23674855
     [Google Scholar]
  55. MoneimA.A. MorsyB.M. MahmoudA.M. SeifA.M.A. ZanatyM.I. Beneficial therapeutic effects of Nigella sativa and/or Zingiber officinale in HCV patients in Egypt.EXCLI J.201312943955 27298610
     [Google Scholar]
  56. OyeroO.G. ToyamaM. MitsuhiroN. Selective inhibition of hepatitis c virus replication by Alpha-zam, a Nigella sativa seed formulation.Afr. J. Tradit. Complement. Altern. Med.201613614414810.21010/ajtcam.v13i6.20 28480371
     [Google Scholar]
  57. GhamdiA.S.S. Nigella sativa seeds protect from viral hepatitis B virus infection.Curr. Top. Pharmacol.200812101104
     [Google Scholar]
  58. HaronA.S. AlwiS.S.S. YazanS.L. Cytotoxic effect of thymoquinone-loaded nanostructured lipid carrier (TQ-NLC) on liver cancer cell integrated with hepatitis B genome, Hep3B.Evid. Based Complement. Alternat. Med.201820181154980510.1155/2018/1549805 30186351
     [Google Scholar]
  59. SulkowskiM.S. Viral hepatitis and HIV coinfection.J. Hepatol.200848235336710.1016/j.jhep.2007.11.009 18155314
     [Google Scholar]
  60. PlattL. EasterbrookP. GowerE. Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis.Lancet Infect. Dis.201616779780810.1016/S1473‑3099(15)00485‑5 26922272
     [Google Scholar]
  61. LeumiS. BignaJ.J. AmougouM.A. NgouoA. NyagaU.F. NoubiapJ.J. Global burden of hepatitis B infection in people living with human immunodeficiency virus: A systematic review and meta-analysis.Clin. Infect. Dis.202071112799280610.1093/cid/ciz1170 31813969
     [Google Scholar]
  62. PlattL. FrenchC.E. McGowanC.R. Prevalence and burden of HBV co‐infection among people living with HIV: A global systematic review and meta‐analysis.J. Viral Hepat.202027329431510.1111/jvh.13217 31603999
     [Google Scholar]
  63. MaideenN.M. Miracle herb to cure HIV-black seeds (Nigella sativa): A review.Int J Med Rev202183116121
     [Google Scholar]
  64. MaideenN.M.P. Potential of black seeds (Nigella sativa) in the management of COVID-19 among children.Int J Med Device Adjuv Treat20214e366
     [Google Scholar]
  65. MaideenN.M. RajkapoorB. SudhaM. MirunaliniG. MohamedR. Therapeutic potentials of black seeds (Nigella sativa) in the management of COVOD-19-a review of clinical and in silico studies.Antiinfect. Agents202220e020822207222
     [Google Scholar]
  66. MaideenN.M.P. HaddaT.B. AlmalkiF.A. MoueqquitM. KawsarS.M.A. Black seeds (Nigella sativa) for the management of COVID-19 in pregnant and breastfeeding women: An insight.J Compl Alt Med Res2023232142610.9734/jocamr/2023/v23i2473
     [Google Scholar]
  67. MollaS.M. AzadA.K. HasibA.M.A. A review on antiviral effects of Nigella sativa L.Pharmacologyonline201924753
     [Google Scholar]
  68. BasurraR.S. WangS.M. AlhootM.A. Nigella sativa (black seed) as a natural remedy against viruses.J. Pure Appl. Microbiol.2021151294110.22207/JPAM.15.1.26
     [Google Scholar]
  69. ChangC.J. KoY.C. LiuH.W. Serum alanine aminotransferase levels in relation to hepatitis B and C virus infections among drug abusers in an area hyperendemic for hepatitis B.Dig. Dis. Sci.200045101949195210.1023/A:1005690517074 11117565
     [Google Scholar]
  70. KumarA. PantS. NarangS. Significance of alanine aminotransferase testing in diagnosis of acute and chronic HBV infection.Asian Pac. J. Cancer Prev.200910611711172 20192606
     [Google Scholar]
  71. ZentellaC.M.L. MuñozH.R. Is liver enzyme release really associated with cell necrosis induced by oxidant stress?Oxid. Med. Cell. Longev.201620161352914910.1155/2016/3529149 26798419
     [Google Scholar]
  72. DuanM. ChiX. XiaoH. LiuX. ZhuangH. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.Hepatol. Int.202115231832710.1007/s12072‑021‑10153‑2 33638049
     [Google Scholar]
  73. MukherjeeR. BurnsA. RoddenD. Diagnosis and management of hepatitis C virus infection.SLAS Technol.201520551953810.1177/2211068214563794 25609256
     [Google Scholar]
  74. AziziN. AminiM.R. DjafarianK. BidarS.S. The effects of Nigella sativa supplementation on liver enzymes levels: A systematic review and meta-analysis of randomized controlled trials.Clin. Nutr. Res.2021101728210.7762/cnr.2021.10.1.72 33564654
     [Google Scholar]
  75. RazmpooshE. SafiS. AbdollahiN. The effect of Nigella sativa on the measures of liver and kidney parameters: A systematic review and meta-analysis of randomized-controlled trials.Pharmacol. Res.202015610476710.1016/j.phrs.2020.104767 32201245
     [Google Scholar]
  76. TiwariA. G S, Meka S, Varghese B, Vishwakarma G, Adela R. The effect of Nigella sativa on non-alcoholic fatty liver disease: A systematic review and meta-analysis.Hum. Nutr. Metab.20222820014610.1016/j.hnm.2022.200146
     [Google Scholar]
  77. MohtashamianA. EbrahimzadehA. ShamekhiZ. SharifiN. Nigella sativa supplementation and non-alcoholic fatty liver disease: A systematic review of clinical trials.Avicenna J. Phytomed.20231311833 36698733
     [Google Scholar]
  78. TangG. ZhangL. TaoJ. WeiZ. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized controlled trials.Phytother. Res.20213584183419310.1002/ptr.7080 33728708
     [Google Scholar]
  79. ZakariaM.K. SankhyanA. AliA. FatimaK. AzharE. QadriI. HBV/HCV infection and inflammation.J. Genet.2014551000241
     [Google Scholar]
  80. MontazeriR.S. FatahiS. SohouliM.H. The effect of Nigella sativa on biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomized controlled trials.J. Food Biochem.2021454e13625
     [Google Scholar]
  81. MalekianS. AbdollahiG.N. MirghafourvandM. KhaliliF.A. The effect of Nigella sativa on oxidative stress and inflammatory biomarkers: A systematic review and meta-analysis.J. Complement. Integr. Med.202118223525910.1515/jcim‑2019‑0198 34187123
     [Google Scholar]
  82. KavyaniZ. MusazadehV. hamedani GS, Moridpour AH, Vajdi M, Askari G. The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: An updated systematic review and meta-analysis of randomized controlled trials.Inflammopharmacology20233131149116510.1007/s10787‑023‑01213‑0 37036558
     [Google Scholar]
  83. MohitM. FarrokhzadA. FarajiS.N. EsfahaniH.N. KafeshaniM. Effect of Nigella sativa L. supplementation on inflammatory and oxidative stress indicators: A systematic review and meta-analysis of controlled clinical trials.Complement. Ther. Med.20205410253510.1016/j.ctim.2020.102535 33183658
     [Google Scholar]
  84. TavakolyR. ArabA. VallianouN. The effect of Nigella sativa L. supplementation on serum C-reactive protein: A systematic review and meta‐analysis of randomized controlled trials.Complement. Ther. Med.20194514915510.1016/j.ctim.2019.06.008 31331553
     [Google Scholar]
  85. HiggsM.R. ChouteauP. LeratH. ‘Liver let die’: Oxidative DNA damage and hepatotropic viruses.J. Gen. Virol.2014955991100410.1099/vir.0.059485‑0 24496828
     [Google Scholar]
  86. IvanovA.V. EllistonV.V.T. TyurinaD.A. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.Oncotarget2017833895393210.18632/oncotarget.13904 27965466
     [Google Scholar]
  87. ArdianaM. PikirB.S. SantosoA. HermawanH.O. FarabiA.M.J. Effect of Nigella sativa supplementation on oxidative stress and antioxidant parameters: A meta-analysis of randomized controlled trials.ScientificWorldJournal202020201710.1155/2020/2390706 32454800
     [Google Scholar]
  88. HallajzadehJ. MilajerdiA. MobiniM. Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: A systematic review and meta‐analysis of randomized controlled clinical trials.Phytother. Res.202034102586260810.1002/ptr.6708 32394508
     [Google Scholar]
  89. SchmidtJ. BlumH.E. ThimmeR. T-cell responses in hepatitis B and C virus infection: Similarities and differences.Emerg. Microbes Infect.2013211810.1038/emi.2013.14 26038456
     [Google Scholar]
  90. ShoukryN.H. WalkerC.M. T cell responses during HBV and HCV infections: Similar but not quite the same?Curr. Opin. Virol.202151808610.1016/j.coviro.2021.08.011 34619514
     [Google Scholar]
  91. MajdalawiehA.F. FayyadM.W. Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review.Int. Immunopharmacol.201528129530410.1016/j.intimp.2015.06.023 26117430
     [Google Scholar]
  92. FiglonC.K. WojciechowiczK. WardowskaA. LisowskaK.A. The immunomodulatory effect of Nigella sativa.Antioxidants2023127134010.3390/antiox12071340 37507880
     [Google Scholar]
  93. ShoaibA. JavedS. WahabS. Cellular, molecular, pharmacological, and nano-formulation aspects of thymoquinone—A potent natural antiviral agent.Molecules20232814543510.3390/molecules28145435 37513307
     [Google Scholar]
/content/journals/iddt/10.2174/0118715265331112250115061024
Loading
Clinical and In vitro Data Shed New Light on the Therapeutic Advantages of Black Seeds (Nigella sativa) for the Treatment of Hepatitis C and Hepatitis B Viral Infections
Infect. Disord. Drug Targets 25, e18715265331112 (2025); https://doi.org/10.2174/0118715265331112250115061024
/content/journals/iddt/10.2174/0118715265331112250115061024
/content/journals/iddt/10.2174/0118715265331112250115061024
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): black seeds; Hepatitis B virus; hepatitis C virus; kalonji; Nigella sativa; thymoquinone

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test